Regal Assets Analytics

FDA Creating New Investment Opportunities in BioTech Stocks

By |2019-03-07T16:04:02-05:00November 5th, 2018|Tags: , , , |

Because FDA marketing clearance to sell a drug or device in the US remains the brass ring for medical manufacturers [...]

SanaCurrents Introduction – Turn to the Biotech Experts to Maximize Your Returns

By |2019-05-03T11:54:55-04:00November 4th, 2018|Tags: , , , , , , |

Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious and sophisticated biotech investor. Founder of SanaCurrents, Bill Langbein, finally [...]

Repro Med – REPR – Shares Stable on Heels of 2016 Second Quarter Results

By |2016-09-26T16:48:37-04:00September 26th, 2016|Tags: , , , |

Shares of Repro Med (OOTC:REPR) are little changed following the company's 2016 second quarter results.  We view this as an encouraging [...]

Go to Top